Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice

Published:2013-09 Issue:5 Volume:188 Page:608-612
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Grosset Jacques H.,Tyagi Sandeep,Almeida Deepak V.,Converse Paul J.,Li Si-Yang,Ammerman Nicole C.,Bishai William R.,Enarson Donald,Trébucq Arnaud

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference23 articles.

1. Antituberculosis Activity in the Phenazine Series. Isomeric Pigments Obtained by Oxidation of o-Phenylenediamine Derivatives

2. A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity

3. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic

4. A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-throughput Screening of Compounds against Autoluminescent NonreplicatingMycobacterium tuberculosisunder Diverse Conditions;2024-03-11

2. Shortened Treatment Regimens for Drug Sensitive TB;Indian Journal of Pediatrics;2023-12-15

3. Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation;Biomaterials Advances;2023-11

4. Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens;PLOS Computational Biology;2023-06-15

5. Molecular diagnostics and potential therapeutic options for mycobacterium tuberculosis: Where we stand;Medicine in Omics;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3